800 NMOSD patients join landmark registry to unlock disease secrets
NCT ID NCT04886492
First seen Feb 16, 2026 · Last updated May 20, 2026 · Updated 13 times
Summary
This study is a registry that will follow about 800 adults with neuromyelitis optica spectrum disorder (NMOSD) across North America. Researchers will collect information on how the disease presents, progresses, and is managed over time. The goal is to better understand NMOSD and improve future care. Participants must have a confirmed diagnosis and cannot have had a recent relapse or be in a blinded drug trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.